Evidence map›Paper›PMID 40027847›Full record

ReviewOpen respiratory archives2024

[Sleep Innovation].

Laura Vigil, Toni Zapata, Andrea Grau, Marta Bonet, Montserrat Montaña, María Piñar

Abstract readEnglish AbstractReview
In one paragraph

Review in Open respiratory archives, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura VigilUnidad Multidisciplinar del Sueño, Servicio de Neumología, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Barcelona, España.
Toni ZapataUnidad Multidisciplinar del Sueño, Servicio de Neumología, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Barcelona, España.
Andrea GrauUnidad Multidisciplinar del Sueño, Servicio de Neumología, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Barcelona, España.
Marta BonetUnidad Multidisciplinar del Sueño, Servicio de Neumología, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Barcelona, España.
Montserrat MontañaUnidad Multidisciplinar del Sueño, Servicio de Neumología, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Barcelona, España.
María PiñarUnidad Multidisciplinar del Sueño, Servicio de Neumología, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Barcelona, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in sleep medicine have driven significant improvements in the diagnosis and treatment of sleep disorders such as obstructive sleep apnea (OSA). This disorder affects one billion people worldwide and traditionally, diagnosis is based on polysomnography (PSG), a laborious method that requires specialized personnel. However, the integration of artificial intelligence (AI) in sleep medicine has made it possible to automate the analysis of sleep phases and respiratory events with high accuracy.Machine learning algorithms and neural networks have proven to be effective in automatic sleep coding, with hit rates comparable to those of human experts. These advances make it possible to improve the efficiency of sleep labs and to personalize OSA treatment. In addition, techniques such as cluster analysis are used to identify symptomatic patterns and phenotypes, which improves understanding of OSA pathophysiology and optimizes CPAP treatment.However, implementation of AI in hospitals faces technological, ethical, and legal barriers. Challenges include data quality, patient privacy, and the need for specialized personnel. Despite these obstacles, AI and Big Data have the potential to transform medical care for sleep disorders, improving both diagnosis and treatment adherence, provided regulatory and cultural barriers are overcome.

Indexed as

Artificial intelligenceMachine learningSleep apnea

Identifiers

PMID40027847
PMCPMC11869491

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.